Marshall Wace’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.2M Buy
+933,464
New +$3.73M ﹤0.01% 1383
2025
Q1
Sell
-110,304
Closed -$427K 2892
2024
Q4
$427K Buy
110,304
+37,810
+52% +$250K ﹤0.01% 2104
2024
Q3
$475K Sell
72,494
-22,720
-24% -$183K ﹤0.01% 1937
2024
Q2
$690K Sell
95,214
-4,574
-5% -$35K ﹤0.01% 1833
2024
Q1
$757K Buy
+99,788
New +$778K ﹤0.01% 1764
2023
Q2
Sell
-58,908
Closed -$267K 2746
2023
Q1
$267K Buy
+58,908
New +$308K ﹤0.01% 2333
2022
Q4
Sell
-38,710
Closed -$124K 3203
2022
Q3
$124K Buy
+38,710
New +$97K ﹤0.01% 3160
2022
Q1
Sell
-11,392
Closed -$124K 3722
2021
Q4
$124K Sell
11,392
-15,195
-57% -$169K ﹤0.01% 3328
2021
Q3
$306K Buy
26,587
+2,093
+9% +$25.1K ﹤0.01% 2639
2021
Q2
$240K Sell
24,494
-29,620
-55% -$335K ﹤0.01% 2398
2021
Q1
$790K Buy
+54,114
New +$983K ﹤0.01% 1770
2015
Q2
Sell
-2,198
Closed -$1.04M 977
2015
Q1
$1.04M Buy
+2,198
New +$1.04M 0.01% 568
2014
Q4
Sell
-7,062
Closed -$1.67M 889
2014
Q3
$1.67M Buy
+7,062
New +$1.6M 0.02% 476

Other funds holding LRMR